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Background:  transcatheter aortic valve implantation (TAVI) is a widely used procedure for high surgical risk patients affected by severe 
symptomatic aortic stenosis (SSAS). The development of post-procedural paravalvular leak (PVL) represents a risk factor for worse 
outcome. Aim of this study is to investigate the effect of post-procedural PVL on long-term clinical outcomes and its correlation with pre-
existent aortic regurgitation (AR).
methods:  we retrospectively analysed data from patients affected by SSAS undergoing TAVI prospectively collected in the Italian 
Transcatheter balloon-Expandable Registry (ITER). The presence and the degree of pre-procedural AR and PVL were assessed by 
Doppler-measurements and stratified as ASE/ESE guidelines: absent-trivial (0/3), mild (1/3), and moderate/relevant (≥2/3).
results:  1904 patients at 33 centres underwent TAVI between 2007 and 2012. One-hundred thirty-seven patients with 30-day/in-hospital 
mortality and five patients lost at follow-up were excluded from the analysis. The remaining 1762 patients where included in the study. 
Median follow-up time was 821 days (IQR 585.75). Median age was 82.5 years (IQR 7.6), 39% were female, Logistic EuroSCORE and 
EuroSCORE II were 17 (IQR 14.3) and 5 (IQR 5.8), respectively. Baseline AR was absent in 676 patients (40%), 707 (42%) had a mild 
AR and 312 (18%) presented moderate/relevant AR. After TAVI 1083 patients (63%) did not show PVL, 539 (32%) had a mild PVL and 86 
(5%) had at least moderate PVL. Kaplan Meier analysis showed that PVL of any grade influenced negatively the overall survival (HR 1.42; 
CI 1.17-1.42 p<0.001). The percentage of patients with a functional NYHA class more than II was higher in patients who presented PVL 
(p=0.076). No protective action of pre-existing AR on overall mortality (HR 1.01; CI 0.74-1.37 p=0.97) and NYHA functional class (OR 0.89; 
IC 0.48-1.63 p=0.7) was detected in patients that developed PVL.
conclusion:  Pre-existing AR has no protective effect on survival in case of post-procedural PVL. Any grade of PVL negatively affect both 
overall survival and functional class.
